NCT00811226View on ClinicalTrials.gov

Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)

CompletedOBSERVATIONAL

Enrollment

450

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Hypertension

Interventions

DRUG

olmesartan medoxomile alone or combined with hydrochlorothiazide,

olmesartan medoxomile 20mg/daily or 40mg/daily; olmesartan medoxomile 20mg plus 12.5 mg of hydrochlorothiazide daily; olmesartan medoxomile 40mg plus 12.5 mg of hydrochlorothiazide daily